Elevated levels of oxidized nucleosides in individuals with the JAK2V617F mutation from a general population study-Reference-Cited by-同舟云学术

Elevated levels of oxidized nucleosides in individuals with the JAK2V617F mutation from a general population study

Published:2021-05 Issue: Volume:41 Page:101895
ISSN:2213-2317
Container-title:Redox Biology
language:en
Short-container-title:Redox Biology

Author:

Sørensen Anders L.^ORCID,Hasselbalch Hans C.,Bjørn Mads Emil,Nielsen Claus H.,Cordua Sabrina^ORCID,Skov Vibe^ORCID,Kjær Lasse,Poulsen Henrik E.,Ellervik Christina

Funder

TrygFonden

Region Sjaelland

Næstved Sygehus

Chief Physician Johan Boserup and Lise Boserups Scholarship

Publisher

Elsevier BV

Subject

Organic Chemistry,Biochemistry,Clinical Biochemistry

Reference29 articles.

1. Whole blood transcriptional profiling reveals deregulation of oxidative and antioxidative defence genes in myelofibrosis and related neoplasms. Potential implications of downregulation of Nrf2 for genomic instability and disease progression;Hasselbalch;PloS One,2014

2. A role for reactive oxygen species in JAK2 V617F myeloproliferative neoplasm progression;Marty;Leukemia,2013

3. Activated Jak2 with the V617F point mutation promotes G1/S phase transition;Walz;J. Biol. Chem.,2006

4. Oxidative stress is increased in primary and post-polycythemia vera myelofibrosis;Vener;Exp. Hematol.,2010

5. Increased reactive oxygen species production and p47phox phosphorylation in neutrophils from myeloproliferative disorders patients with JAK2 (V617F) mutation;Hurtado-Nedelec;Haematologica,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxidized mitochondrial DNA activates the cGAS-STING pathway in the neuronal intrinsic immune system after brain ischemia-reperfusion injury;Neurotherapeutics;2024-07

2. Assessment of Total Antioxidant Capacity, 8-Hydroxy-2′-deoxy-guanosine, the Genetic Landscape, and Their Associations in BCR::ABL-1-Negative Chronic and Blast Phase Myeloproliferative Neoplasms;International Journal of Molecular Sciences;2024-06-17

3. JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms;European Journal of Haematology;2024-01-16

4. Recent approaches to the liquid chromatography-mass spectrometry analysis of modified deoxynucleosides as biomarkers in clinical research;TrAC Trends in Analytical Chemistry;2023-11

5. Pronounced gut microbiota signatures in patients with JAK2V617F- positive essential thrombocythemia;Microbiology Spectrum;2023-10-17